Dazostinag (Tak-676) Alone And In Combination With Pembrolizumab (Pembro) In Patients (Pts) With Advanced Or Metastatic Solid Tumors: Preliminary Safety, Pk/Pd, And Anti-Tumor Activity In A Phase I Dose Escalation Study Supporting A Recommended Dose For Expansion (Rde)
TAK-676;Pembrolizumab
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Dazostinag (Tak-676) Alone And In Combination With Pembrolizumab (Pembro) In Patients (Pts) With Advanced Or Metastatic Solid Tumors: Preliminary Safety, Pk/Pd, And Anti-Tumor Activity In A Phase I Dose Escalation Study Supporting A Recommended Dose For Expansion (Rde) ### Output: TAK-676;Pembrolizumab